Effectiveness of triple therapy with direct-acting antivirals for hepatitis C genotype 1 infection: application of propensity score matching in a national HCV treatment registry (Q33576871)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Effectiveness of triple therapy with direct-acting antivirals for hepatitis C genotype 1 infection: application of propensity score matching in a national HCV treatment registry	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Effectiveness of triple therapy with direct-acting antivirals for hepatitis C genotype 1 infection: application of propensity score matching in a national HCV treatment registry (English)

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

author name string

Emma Gray

1

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

David J Pasta

2

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Suzanne Norris

3

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Aisling O'Leary

4

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Irish Hepatitis C Outcomes and Research Network (ICORN)

5

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

publication date

19 April 2017

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

BMC Health Services Research

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

17

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

288

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Real-life experience with first generation HCV protease inhibitor therapy in Germany: The prospective, non-interventional PAN cohort

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5395881

21 June 2018

Predictive factors associated with hepatitis C antiviral therapy response

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5395881

21 June 2018

Safety profile of boceprevir and telaprevir in chronic hepatitis C: real world experience from HCV-TARGET.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5395881

21 June 2018

Personalized cost-effectiveness of boceprevir-based triple therapy for untreated patients with genotype 1 chronic hepatitis C.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5395881

21 June 2018

Predictors of the therapeutic response in hepatitis C. A 2013 update

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5395881

21 June 2018

Observational research--opportunities and limitations

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5395881

21 June 2018

How to optimize HCV therapy in genotype 1 patients: predictors of response.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5395881

21 June 2018

Hepatitis C: epidemiology, diagnosis, natural history and therapy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5395881

21 June 2018

Response-guided telaprevir combination treatment for hepatitis C virus infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5395881

21 June 2018

An update on treatment of genotype 1 chronic hepatitis C virus infection: 2011 practice guideline by the American Association for the Study of Liver Diseases

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5395881

21 June 2018

An Introduction to Propensity Score Methods for Reducing the Effects of Confounding in Observational Studies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5395881

21 June 2018

Telaprevir for Retreatment of HCV Infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5395881

21 June 2018

Telaprevir for Previously Untreated Chronic Hepatitis C Virus Infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5395881

21 June 2018

Boceprevir for previously treated chronic HCV genotype 1 infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5395881

21 June 2018

Boceprevir for untreated chronic HCV genotype 1 infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5395881

21 June 2018

Observational studies: a valuable source for data on the true value of RA therapies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5395881

21 June 2018

The Role of Observational Investigations in Comparative Effectiveness Research

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5395881

21 June 2018

The performance of different propensity-score methods for estimating differences in proportions (risk differences or absolute risk reductions) in observational studies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5395881

21 June 2018

Diagnosis, management, and treatment of hepatitis C: an update

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5395881

21 June 2018

Study design, precision, and validity in observational studies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5395881

21 June 2018

The challenge of selection bias and confounding in palliative care research

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5395881

21 June 2018

From randomized controlled trials to observational studies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5395881

21 June 2018

A critical appraisal of propensity-score matching in the medical literature between 1996 and 2003.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5395881

21 June 2018

Propensity-score matching in the cardiovascular surgery literature from 2004 to 2006: a systematic review and suggestions for improvement

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5395881

21 June 2018

Using real-world data for coverage and payment decisions: the ISPOR Real-World Data Task Force report.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5395881

21 June 2018

Methods to adjust for bias and confounding in critical care health services research involving observational data

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5395881

21 June 2018

Bayesian methods for evidence synthesis in cost-effectiveness analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5395881

21 June 2018

Global registries for measuring pharmacoeconomic and quality-of-life outcomes: focus on design and data collection, analysis and interpretation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5395881

21 June 2018

Observational research methods. Research design II: cohort, cross sectional, and case-control studies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5395881

21 June 2018

Representation of the elderly, women, and minorities in heart failure clinical trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5395881

21 June 2018

Study subjects and ordinary patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5395881

21 June 2018

The clinical relevance of observational research

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5395881

21 June 2018

Understanding controlled trials: Why are randomised controlled trials important?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5395881

21 June 2018

Prospective observational studies to assess comparative effectiveness: the ISPOR good research practices task force report

1 reference

https://api.crossref.org/works/10.1186%2FS12913-017-2188-1

21 January 2018

De testimonio: on the evidence for decisions about the use of therapeutic interventions

1 reference

https://api.crossref.org/works/10.1186%2FS12913-017-2188-1

21 January 2018

Importance of observational studies in clinical practice.

1 reference

https://api.crossref.org/works/10.1186%2FS12913-017-2188-1

21 January 2018

Determination of the burden of hepatitis C virus infection in Ireland

1 reference

https://api.crossref.org/works/10.1186%2FS12913-017-2188-1

21 January 2018

Revisiting the predictors of a sustained virologic response in the era of direct-acting antiviral therapy for hepatitis C virus

1 reference

https://api.crossref.org/works/10.1186%2FS12913-017-2188-1

21 January 2018

Factors that predict response of patients with hepatitis C virus infection to boceprevir

1 reference

https://api.crossref.org/works/10.1186%2FS12913-017-2188-1

21 January 2018

The Relative Ability of Different Propensity Score Methods to Balance Measured Covariates Between Treated and Untreated Subjects in Observational Studies

1 reference

https://api.crossref.org/works/10.1186%2FS12913-017-2188-1

21 January 2018

Importance of observational studies in clinical practice

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5395881

31 October 2018

Opportunities for minimization of confounding in observational research

1 reference

https://pubmed.ncbi.nlm.nih.gov/28424064

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The value of observational research in liver diseases

1 reference

https://pubmed.ncbi.nlm.nih.gov/28424064

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Why Observational Studies Should Be Among The Tools Used In Comparative Effectiveness Research

1 reference

https://pubmed.ncbi.nlm.nih.gov/28424064

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Can observational studies approximate RCTs?

1 reference

https://pubmed.ncbi.nlm.nih.gov/28424064

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparative effectiveness research: what is it and why do we need it in nephrology?

1 reference

https://pubmed.ncbi.nlm.nih.gov/28424064

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1186/S12913-017-2188-1

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33576871&oldid=2195513770"